Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia

Neoplasma

Volumn 50, Issue 6, 2003, Pages 447-451

  Werynska B ^a   Ramlau, R ^b   Podolak Dawidziak, M ^a   Jankowska, R ^a   Prajs, I ^a   Usnarska Zubkiewicz, L ^a   Kuliczkowski, K ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Oncology Department   (Poland)

Author keywords

Essential thrombocythemia; Fibrinogen; Lung cancer; Thrombocytosis; Thrombopoietin

Indexed keywords

FIBRINOGEN; THROMBOPOIETIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDBACK SYSTEM; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; REACTIVE THROMBOCYTOSIS; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOPOIESIS; THROMBOCYTOSIS;

EID: 18744436874     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. ANREASSON B, LINDSTEDT G, STOCKELBERG D, WADENVIK H, KUTTI J. The relation between plasma thrombopoietin and erythropoietin concentrations in polycythaemia vera and essential thrombocythaemia. Leuk Lymphoma 2001; 41: 579-584.
2. CERUTTI A, CUSTODI P, DURANTI M, NORIS P, BALDUINI CL. Thrombopoietin levels in patients with primary and reactive thrombocytosis. Br J Haematol 1997; 99: 281-284.
3. COLOMBI M, RADAELLI F, ZOCCHI L, MAIOLO AT. Thrombotic and hemorrhagic complications in essential thrombocythemia: a retrospective study of 103 patients. Cancer 1991; 67: 2926-2930.
4. CORTELAZZO S, VIERO P, FINAZZI G, D'EMILIO A, RODEGHIERO F, BARBUI T. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 1990; 3: 556-562.
5. DEHMEL GG, DREXLER HG. Expression of thrombopoietin and thrombopoietin receptor MPL in human leukemia-lymphoma and solid tumor cell lines. Lek Res 1996; 20: 831-838.
6. ESPANOL I, HERNANDEZ A, CORTES M, MATEO J, PUJOL-MOIX N. Patients with hrombocytosis have normal or slightly elevated thrombopoietin levels. Haematologica 1999; 84: 312-316.
7. FRENKEL EP. Southwestern Internal Medicine Conference: The clinical spectrum of thrombocytosis and thrombocythemia. Am J Med Sci 1991; 301: 69-80.
8. GASTL G, PLANTE M, FINSTAD CL, WONG GY, FEDERICI MG, BANDER NH, RUBIN SC. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Br J Haematol 1993; 83: 433-441.
9. GRIESSHAMMER M, HORNKOHL A, NICHOL JL, HECHT T, RAGHAVACHAR A, HEIMPEL H, SCHREZENMEIER H. High levels of thrombopoietin in sera of patients with essential thrombocythemia: Cause or consequence of abnormal platelet production? Ann Hematol 1998; 77: 211-215.
10. HARRISON CN, GALE RE, MACHIN SJ, LINCH DC. A large proportion of patients with a diagnosis of essential thrombocythaemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood 1999; 93: 417-425.
11. HARRISON CN, GALE RE, PEZELLA F, MIRE-SLUIS A, MACHIN SJ, LINCH DC. Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. Br J Haematol 1999; 107: 139-147.
12. HOLLEN CW, HENTHORN J, KOZIOL JA, BURNSTEIN SA. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol 1991; 79: 286-290.
13. HOU M, CARNESKOG J, MELLOVIST UH, STOCKELBERG D, HEDBERG M, WADENVIK H, KUTTI J. Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocythaemia and reactive thrombocytosis. Eur J Haematol 1998; 61: 119-122.
14. HSU HC, TSAI WH, JIANG ML, HO CH, HSU ML, HO CK, WANG SY. Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis. J Lab Clin Med 1999; 134: 392-397.
15. KOMURA E, MATSUMURA T, KATO T, TAHARA T, TSUMODA Y, SAWADA T. Thrombopoietin in patients with hepatoblastoma. Stem Cells 1998; 16: 329-333.
16. KUTER DJ, BEELER DL, ROSENBERG RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA, 1994; 91: 11104-11108.
17. LEVIN J, CONLEY CL. Thrombocytosis associated with malignancy. Arch Intern Med 1964; 114: 497-500.
18. LI J, XIA Y, KUTER DJ. The platelet thrombopoietin receptor number and function at markedly decreased in patients with essential thrombocythaemia. Br J Haematol 2000; 111: 943-953.
19. MOROWITZ DA, ALLEN LW, KIRSNER JB. Thrombocytosis in chronic inflammatory bowel disease. Ann Intern Med 1968; 18: 1013-1021.
20. MURPHY S, ILAND H, ROSENTHAL D, LASZLO J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 1986; 23: 177-182.
21. MURPHY S, PETERSON P, ILAND H, LASZLO J. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 1997; 34: 29-39.
22. PITCHER L, TAYLOR K, NICHOL J, SELSI D, RODWEL R, MARTY J, TAYLOR D, WRIGHT S, MOORE D, KELLY C, RENTOUL A. Thrombopoietin measurement in thrombocytosis: dysregulation and lack of feedback inhibition in essential thrombocythaemia. Br J Haematol 1997; 99: 929-932.
23. PODOLAK-DAWIDZIAK M, WRÓBEL T, JELEN M, POJDA Z. Concentration of interleukin 6 (IL-6) in the serum of patients with myeloproliferative disorders (MPD) and secondary thrombocytosis. Acta Haemat Pol 1998; 29: 251-258.
24. PODOLAK-DAWIDZIAK M, WRÓBEL T, POJDA Z, KOTLAREK-HAUS S. Serum IL-6 in myeloproliferative syndrome and secondary thrombocytosis. Br J Haematol 1996; 93 Suppl 2: 894.
25. SASAKI Y, TAKAHASHI T, MIYAZAKI H, MATSUMOTO A, KATO T, NAKAMURA K, IHO S, SKUNO Y, NAKAO K. Production of thrombopoietin by human carcinomas and its novel isoforms. Blood 1999; 94: 1952-1960.
26. TAHARA T, USUKI K, SATO H, OHASI H, MORITA H, TSUMURA H, MATSUMOTO A, MIAZAKI H, URABE A, KATO T. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Br J Haematol 1996; 93: 783-788.
27. TEFFERI A, HO TC, AHMANN GJ, KATZNANN JA, GREIPP PR. Plasma interleukin 6 and C-reactive protein levels in reactive versus clonal thrombocytosis. Am J Med 1994; 97: 374-378.
28. TEFFERI A, MURPHY S. Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management. Blood Rev 2001; 15: 121-131.
29. UPPENKAMP M, MAKAROVA E, PETRASCH S, BRITTINGER G. Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis. Ann Hematol 1998; 77: 217-223.
30. WANG JC, CHEN C, NOVETSKY AD, LICHTER SM, AHMED F, FRIEDBERG NM. Blood thrombopoietin levels in clonal and reactive thrombocytosis. Am J Med 1998; 104: 451-455.
31. WERYNSKA N, RAMLAU R, PODOLAK-DAWIDZIAK M, JANKOWSKA R, KULICZKOWSKI K, GOŁECKI M, PRAJS I. Serum levels of thrombopoietin (TPO) in patients with thrombocytosis due to lung cancer and in essential thrombocythaemia (ET). Eur Resp J, 11th ERS Anual Congress, Berlin, Germany, Sept. 22-26, 2001; 18 Suppl 33: 234.